Quarterly report [Sections 13 or 15(d)]

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

v3.25.4
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Aug. 31, 2024   $ 80 $ 175,125 $ (45,503) $ 129,702
Balance (in shares) at Aug. 31, 2024 432,513 24,063,894      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Restricted stock grants     21   21
Restricted stock grants (in shares)   9,200      
Stock options exercised (in shares)   13,815      
Share-based compensation     35   35
Repurchases of common stock       (108) (108)
Repurchases of common stock (in shares)   (10,000)      
Net income       3,937 3,937
Balance at Nov. 30, 2024   $ 80 175,181 (41,674) 133,587
Balance (in shares) at Nov. 30, 2024 432,513 24,076,909      
Balance at Aug. 31, 2025   $ 80 175,448 (32,790) 142,738
Balance (in shares) at Aug. 31, 2025 432,513 24,066,805      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Restricted stock grants     11   11
Restricted stock grants (in shares)   3,800      
Stock options exercised     40   40
Stock options exercised (in shares)   10,000      
Stock granted for services     115   115
Stock granted for services (in shares)   10,000      
Share-based compensation     17   17
Net income       4,565 4,565
Balance at Nov. 30, 2025   $ 80 $ 175,631 $ (28,225) $ 147,486
Balance (in shares) at Nov. 30, 2025 432,513 24,090,605